insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 1998; 47 (10) :1643-9 . Nesto RW. The relation of insulin resistance syndromes to risk of cardiovascular disease. Rev Cardiovasc Med 2003; 4 (6): S11-S18
. Pouliot MC, Desprйs JP, Lemieux S et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994; 73:460-8
. Brunzell JD, Ayyobi AF. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus. Am J Med 2003 Dec 8; 115 Suppl 8A: 24S - 28S
. Robins SJ, Rubins HB, Faas FH et al. Insulin resistance and cardiovascular events with low HDL cholesterol. The Veterans Affairs HDL Intervention Trial (VA-HIT). Diabetes Care 2003; 26 (5) :1513-7
. Steinmetz A, Fenselau S, Schrezenmeir J. Treatment of dyslipoproteinemia in the metabolic syndrome. Exp Clin Endocrinol Diabetes 2001:109: S548-59
. Robins SJ, Collins D, Wittes JT et al. Relation of Gemfibrozil treatment and lipid levels with major coronary events. JAMA 2001; 285:1585-91
